News & HighlightsNews
A protein thought to play a supporting role in DNA replication actually facilitates the whole process
Scientists have discovered that a protein once thought to simply help load a factor necessary for the copying of DNA, actually plays a key role in ensuring fast and reliable replication—an insight that could inform research into cancer and other diseases.
In rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to this one kind of Chikungunya vaccine, which is no longer available in the U.S.
New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders
In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.
Rockefeller startup aims to change the course of treatment for severe autoimmune diseases
Nuvig, a biotech company cofounded by Jeffrey Ravetch, has launched phase two trials and raised $200 million.
Researchers develop a potential IVIG replacement for treating autoimmunity that’s significantly more potent
The discovery could greatly improve patient experience and address supply shortages.
There are countless species of bacteria scientists have never seen. This lab develops techniques that allow scientists to see them.
Their newest technique has already uncovered hundreds of hidden bacterial genomes and two promising antibiotics. Now, the same approach could unlock an entire microbial universe—reshaping drug discovery and our understanding of how bacteria shape our environment.
Hundreds of new bacteria, and two potential antibiotics, found in soil
Newly identified compounds appear effective against drug-resistant bacteria. The technique used to reveal them could uncover many more antibiotics, as well as help illuminate a previously hidden microbial world.
New tool helps predict antibiotic resistance
Using the novel platform could help pharmaceutical companies design longer lasting drugs.
Researchers find CRISPR is capable of even more than we thought
Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.
Rockefeller University Press launches new journal in partnership with scientists
Open access, peer reviewed, and co-owned, the Journal of Human Immunity represents a new business model in scientific publishing.
View
View